✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Aarey Drugs & Pharmaceuticals Ltd.

AAREYDRUGS

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹224 Cr.
P/E
53.99

Aarey Drugs & Pharmaceuticals Ltd.

  • Aarey Drugs & Pharma
  • Oxygenta Pharma
  • Syschem (India)

FAQs on Aarey Drugs & Pharmaceuticals Ltd. Shareprice

Aarey Drugs & Pharma has given better returns compared to its competitors.
Aarey Drugs & Pharma has grown at ~18.39% over the last 10yrs while peers have grown at a median rate of 18.21%

Yes, Aarey Drugs & Pharma is expensive.
Latest PE of Aarey Drugs & Pharma is 53.99, while 3 year average PE is 25.72.
Also latest EV/EBITDA of Aarey Drugs & Pharma is 75.21 while 3yr average is 32.02.

View FAQ's On Business

Growth Table

  • Aarey Drugs & Pharmaceuticals Ltd.
  • Oxygenta Pharma
  • Syschem (India)

Balance Sheet

  • Aarey Drugs & Pharmaceuticals Ltd.
  • Oxygenta Pharma
  • Syschem (India)

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Aarey Drugs & Pharmaceuticals Ltd.
  • Oxygenta Pharma
  • Syschem (India)

Cash Flow

  • Aarey Drugs & Pharmaceuticals Ltd.
  • Oxygenta Pharma
  • Syschem (India)

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Aarey Drugs & Pharmaceuticals Ltd.
  • Oxygenta Pharma
  • Syschem (India)

Quarterly Results

  • Aarey Drugs & Pharmaceuticals Ltd.
  • Oxygenta Pharma
  • Syschem (India)

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Aarey Drugs & Pharmaceuticals Ltd. Financials

Balance sheet of Aarey Drugs & Pharma is strong.
It shouldn't have solvency or liquidity issues.

Yes, The net debt of Aarey Drugs & Pharma is increasing.
Latest net debt of Aarey Drugs & Pharma is ₹33.38 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹29.66 Crs.

The profit is oscillating.
The profit of Aarey Drugs & Pharma is ₹4.16 Crs for TTM, ₹4.68 Crs for Mar 2024 and ₹3.77 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Aarey Drugs & Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech